Invesco Biotechnology & Genome ETF
PBE
PBE
60 hedge funds and large institutions have $92.6M invested in Invesco Biotechnology & Genome ETF in 2013 Q4 according to their latest regulatory filings, with 15 funds opening new positions, 21 increasing their positions, 10 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
4.78% more ownership
Funds ownership: 27.71% → 32.49% (+4.8%)
Holders
60
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$9.61M | |
| 2 | +$7.38M | |
| 3 | +$5.49M | |
| 4 |
Wells Fargo
San Francisco,
California
|
+$4.93M |
| 5 |
AIG
American International Group
New York
|
+$714K |
Top Sellers
| 1 | -$1.82M | |
| 2 | -$676K | |
| 3 | -$661K | |
| 4 |
WBG
Wharton Business Group
Malvern,
Pennsylvania
|
-$303K |
| 5 |
NCM
Niemann Capital Management
Stateline,
Nevada
|
-$247K |